An Overview of Cancer in Djibouti: Current Status, Therapeutic Approaches, and Promising Endeavors in Local Essential Oil Treatment
-
Published:2023-11-16
Issue:11
Volume:16
Page:1617
-
ISSN:1424-8247
-
Container-title:Pharmaceuticals
-
language:en
-
Short-container-title:Pharmaceuticals
Author:
Abdoul-Latif Fatouma Mohamed1ORCID, Ainane Ayoub2ORCID, Houmed Aboubaker Ibrahim3, Mohamed Jalludin1, Ainane Tarik2ORCID
Affiliation:
1. Medicinal Research Institute, Center for Studies and Research of Djibouti, IRM-CERD, Route de l’Aéroport, Haramous, Djibouti P.O. Box 486, Djibouti 2. Superior School of Technology of Khenifra (EST-Khenifra), University of Sultan Moulay Slimane, P.O. Box 170, Khenifra 54000, Morocco 3. Peltier Hospital of Djibouti, Djibouti City P.O. Box 2123, Djibouti
Abstract
Djibouti, a developing economy, grapples with significant socioeconomic obstacles and the prevalence of infectious pathologies, including certain forms of neoplasms. These challenges are exacerbated by limited access to affordable medical technologies for diagnosis, coupled with a lack of preventive interventions, particularly in disadvantaged areas. The attention devoted to local phytotherapeutic treatments underscores the uniqueness of Djibouti’s flora, resulting from its distinctive geographical position. International focus specifically centers on harnessing this potential as a valuable resource, emphasizing the phytoconstituents used to counter pathologies, notably carcinomas. This comprehensive overview covers a broad spectrum, commencing with an examination of the current state of knowledge, namely an in-depth investigation of oncological risk factors. Essential elements of control are subsequently studied, highlighting the fundamental prerequisites for effective management. The significance of dietary habits in cancer prevention and support is explored in depth, while traditional methods are examined, highlighting the cultural significance of indigenous essential oil therapies and encouraging further research based on the promising results.
Subject
Drug Discovery,Pharmaceutical Science,Molecular Medicine
Reference94 articles.
1. Yu, X., Qin, W., Lin, X., Shan, Z., Huang, L., Shao, Q., and Chen, M. (2023). Synergizing the enhanced RIME with fuzzy k-nearest neighbor for diagnose of pulmonary hypertension. Comput. Biol. Med., 165. 2. The age-dependent association of risk factors with pancreatic cancer;Yuan;Ann. Oncol.,2022 3. Jakobsen, E., Olsen, K.E., Bliddal, M., Hornbak, M., Persson, G.F., and Green, A. (2021). Forecasting lung cancer incidence, mortality, and prevalence to year 2030. BMC Cancer, 21. 4. Gutiérrez-Cuevas, J., Lucano-Landeros, S., López-Cifuentes, D., Santos, A., and Armendariz-Borunda, J. (2022). Epidemiologic, genetic, pathogenic, metabolic, epigenetic aspects involved in Nash-hcc: Current therapeutic strategies. Cancers, 15. 5. Metabolic reprogramming in hematologic malignancies: Advances and clinical perspectives;Yu;Cancer Res.,2022
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|